Trevi Therapeutics
TRVI
#7861
Rank
A$0.33 B
Marketcap
$4.33
Share price
2.55%
Change (1 day)
116.91%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2024 (TTM): -A$58.65 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$44.08 Million a decrease over its 2022 earnings that were of -A$43.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$58.65 Million33.07%
2023 -A$44.08 Million2.43%
2022 -A$43.03 Million-14.45%
2021 -A$50.3 Million1.36%
2020 -A$49.63 Million23.64%
2019 -A$40.14 Million27.54%
2018 -A$31.47 Million